Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-7
SponsorTanta University
About this trial
This study aims to compare the efficacy of using oral Melatonin versus nebulized Dexmedetomidine in limitation of emergence agitation in children undergoing adenotonsillectomy.
Eligibility criteria
Qualifiers
Children aged between 3 and 7 years.
Both sexes.
Classified as American Society of Anesthesiologists (ASA) physical status I or II according to the American Society of Anesthesiologists.
Scheduled for elective adenotonsillectomy under general anesthesia.
Disqualifiers
Parental refusal to participate in the study.
Known allergy or hypersensitivity to dexmedetomidine, melatonin or midazolam.
Presence of developmental delay.
Central nervous system disorders.
Trial design
Treatments tested in this trial
- Normal saline
- Oral melatonin syrup
- Nebulized dexmedetomidine
Treatment groups
96 Participants
are divided into 3 treatment groupsLocations
1Tanta University31527, TantaEl-Gharbia, Egypt
Sponsors and collaborators
Tanta University
Lead sponsor
Source ClinicalTrials.gov